S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
What To Do With Your Trades Today (Ad)pixel
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
What To Do With Your Trades Today (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
What To Do With Your Trades Today (Ad)pixel
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
What To Do With Your Trades Today (Ad)pixel
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
What To Do With Your Trades Today (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
What To Do With Your Trades Today (Ad)pixel
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
What To Do With Your Trades Today (Ad)pixel
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
What To Do With Your Trades Today (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
What To Do With Your Trades Today (Ad)pixel
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
What To Do With Your Trades Today (Ad)pixel
UK travelers face hours-long waits for ferries to France
'War of the states': EV, chip makers lavished with subsidies
What To Do With Your Trades Today (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
What To Do With Your Trades Today (Ad)pixel
Shipbuilder Austal executives accused of inflating earnings
No more room for vroom? Paris votes on banishing e-scooters
NASDAQ:ADMP

Adamis Pharmaceuticals - ADMP Stock Forecast, Price & News

$0.12
0.00 (0.00%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.11
$0.13
50-Day Range
$0.10
$0.30
52-Week Range
$0.10
$0.61
Volume
904,839 shs
Average Volume
1.55 million shs
Market Capitalization
$17.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ADMP stock logo

About Adamis Pharmaceuticals (NASDAQ:ADMP) Stock

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.

Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Stock News Headlines

Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Q4 2022 Adamis Pharmaceuticals Corp Earnings Call
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
See More Headlines
Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Company Calendar

Last Earnings
3/31/2022
Today
4/01/2023
Next Earnings (Estimated)
5/15/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADMP
Fax
N/A
Employees
116
Year Founded
2006

Profitability

Net Income
$-26,480,000.00
Net Margins
-556.71%
Pretax Margin
-550.82%

Debt

Sales & Book Value

Annual Sales
$4.76 million
Book Value
($0.01) per share

Miscellaneous

Free Float
148,033,000
Market Cap
$17.38 million
Optionable
Optionable
Beta
1.26

Social Links


Key Executives

  • David J. Marguglio
    President, Chief Executive Officer & Director
  • David C. Benedicto
    Chief Financial Officer
  • Thomas H. Moll
    Vice President-Research
  • Robert H. Uhl
    Investor Relations Contact













ADMP Stock - Frequently Asked Questions

How have ADMP shares performed in 2023?

Adamis Pharmaceuticals' stock was trading at $0.1693 at the beginning of the year. Since then, ADMP stock has decreased by 31.5% and is now trading at $0.1159.
View the best growth stocks for 2023 here
.

Are investors shorting Adamis Pharmaceuticals?

Adamis Pharmaceuticals saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 2,000,000 shares, an increase of 28.2% from the February 28th total of 1,560,000 shares. Based on an average trading volume of 1,280,000 shares, the short-interest ratio is presently 1.6 days.
View Adamis Pharmaceuticals' Short Interest
.

When is Adamis Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 15th 2023.
View our ADMP earnings forecast
.

How were Adamis Pharmaceuticals' earnings last quarter?

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) posted its quarterly earnings results on Thursday, March, 31st. The specialty pharmaceutical company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. Adamis Pharmaceuticals had a negative net margin of 556.71% and a negative trailing twelve-month return on equity of 420.53%. During the same quarter last year, the company earned ($0.16) earnings per share.

What other stocks do shareholders of Adamis Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and OPKO Health (OPK).

What is Adamis Pharmaceuticals' stock symbol?

Adamis Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADMP."

How do I buy shares of Adamis Pharmaceuticals?

Shares of ADMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Adamis Pharmaceuticals' stock price today?

One share of ADMP stock can currently be purchased for approximately $0.12.

How much money does Adamis Pharmaceuticals make?

Adamis Pharmaceuticals (NASDAQ:ADMP) has a market capitalization of $17.38 million and generates $4.76 million in revenue each year.

How many employees does Adamis Pharmaceuticals have?

The company employs 116 workers across the globe.

How can I contact Adamis Pharmaceuticals?

Adamis Pharmaceuticals' mailing address is 11682 EL CAMINO REAL SUITE 300, SAN DIEGO CA, 92130. The official website for the company is www.adamispharmaceuticals.com. The specialty pharmaceutical company can be reached via phone at (858) 997-2400 or via email at mflather@adamispharma.com.

This page (NASDAQ:ADMP) was last updated on 4/2/2023 by MarketBeat.com Staff